HANALL PHARMACEUTICAL CO., LTD.

City:

Daejeon

Country:

South Korea

Published Applications:

Last publication date:

2010-02-25

Patent Grants:

Last grant date:

2010-01-19

Top Inventors for applications by HANALL PHARMACEUTICAL CO., LTD.

These are the the leading inventors for applications assigned to HANALL PHARMACEUTICAL CO., LTD.:

Ja Seong KOO 2 Daejeon, South Korea
Young Gwan JO 2 Daejeon, South Korea
Ju Bin Yim 1 Chungcheongnam-do, South Korea
Sung Wuk Kim 1 Seongnam-si, South Korea

Lila Drittanti 1 Vigneux-sur-Seine, France
Thierry Guyon 1 Palaiseau, France
Sang Ouk Sun 1 Gwangju, South Korea
Manuel Vega 1 Vigneux-sur-Seine, France

Jun Young LEE 1 Daejeon, South Korea
Sung Wuk KIM 1 Gyeonggi-do, South Korea
Sung Soo JUN 1 Gyeonggi-do, South Korea
Rene GANTIER 1 Elancourt, France

Sung-Soo Jun 1 Seongnam-si, South Korea
Jin-Wook Kim 1 Daejeon, South Korea

Recent patent applications by HANALL PHARMACEUTICAL CO., LTD.

HANALL PHARMACEUTICAL CO., LTD. based in Daejeon, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2010-02-25

US20100047341A1

Human necessities

COMBINED PREPARATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BASED ON CHRONOTHERAPY THEORY

#2 | 2008-10-02

US20080241240A1

Human necessities

COMBINED PHARMACEUTICAL FORMULATION WITH CONTROLLED-RELEASE COMPRISING DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS AND HMG-COA REDUCTASE INHIBITORS

#3 | 2007-09-27 ✅ Patent 7,650,243 granted on 2010-01-19

US20070224665A1

Chemistry; metallurgy

Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules

AssigneeID:

217722 ⎘